Q4 2024 Management View CEO Matt Farrell highlighted the company’s strong 2024 performance, including exceeding organic sales ...
Medical device company ResMed (NYSE:RMD) announced in Q4 CY2024, with sales up 10.3% year on year to $1.28 billion. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback